Adenosine and 1,N

Mona Lünswilken, Eugenia Bender-Arnst, Fatima Barakat, Eugen Leinweber, Uwe Beginn, Gabriel A Bonaterra, Ralf Kinscherf

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mona LünswilkenDepartment of Medical Cell Biology, Institute for Anatomy and Cell Biology, Philipps-University of Marburg, Robert-Koch-Str. 8, D-35032 Marburg, Germany.

Eugenia Bender-ArnstOrganic Chemistry I-Bioorganic Chemistry, Institute of Chemistry of New Materials, University of Osnabrück, Barbarastr. 7, D-49076 Osnabrück, Germany.

Fatima BarakatOrganic Chemistry I-Bioorganic Chemistry, Institute of Chemistry of New Materials, University of Osnabrück, Barbarastr. 7, D-49076 Osnabrück, Germany.

Eugen LeinweberOrganic Chemistry I-Bioorganic Chemistry, Institute of Chemistry of New Materials, University of Osnabrück, Barbarastr. 7, D-49076 Osnabrück, Germany.

Uwe BeginnOrganic Chemistry I-Bioorganic Chemistry, Institute of Chemistry of New Materials, University of Osnabrück, Barbarastr. 7, D-49076 Osnabrück, Germany.

Gabriel A BonaterraDepartment of Medical Cell Biology, Institute for Anatomy and Cell Biology, Philipps-University of Marburg, Robert-Koch-Str. 8, D-35032 Marburg, Germany.

Ralf KinscherfDepartment of Medical Cell Biology, Institute for Anatomy and Cell Biology, Philipps-University of Marburg, Robert-Koch-Str. 8, D-35032 Marburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of nucleolipid derivatives based on adenosine and 1,N

Indexed as

AdenosineAntineoplastic AgentsGlioblastomaGliomaAnimalsBrain NeoplasmsCell Line, TumorCell SurvivalHumansHydrophobic and Hydrophilic InteractionsRatsAdenosineAntineoplastic Agentscytotoxicityglioblastomagliomalipophilicitynucleolipidsnucleoside analoguesstructure–activity

Identifiers

PMID42278448

DOI10.3390/ijms27114922

PMCPMC13256577

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.